Profil Financier
August Troendle occupe actuellement le rang #982 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $4.5 B (+$490 sur 24h).
August Troendle is the CEO of Medpace, a clinical research company he founded in Cincinnati, Ohio in 1992; he owns nearly 19% of the stock.
Medpace conducts clinical trials for pharmaceutical companies seeking to bring drugs, vaccines or medical devices to market.
Before starting Medpace, Troendle spent five years as a director at Swiss pharma company Sandoz, now known as Novartis.
He also briefly worked as a medical review officer at the FDA's division of metabolic and endocrine drug products from 1986 to 1987.
A doctor with an M.D. from the University of Maryland, Troendle has also served on the boards of several public and private healthcare companies.